GERD and Eosinophilic Esophagitis

  • Jorge Amil DiasEmail author


GERD and EoE cause chronic esophageal inflammation sharing some common characteristics. Distinction between them requires detailed evaluation of clinical, endoscopic, and histologic features. The interplay between these pathologies is complex and still under active investigation. GERD and EoE may also coexist. The current diagnostic tests may not provide clear-cut differences in diagnosis. Combined clinical, endoscopic, and histologic data may provide the best diagnostic criteria to identify the exact diagnosis and take appropriate therapeutic options.


GERD Eosinophilic esophagitis Eosinophils Mast-cells pH-monitoring Endoscopy Histology Impedance PPI (proton-pump inhibitor) Allergy Food 


  1. 1.
    Winter HS, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23.PubMedGoogle Scholar
  2. 2.
    Kelly KJ, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503–12.CrossRefPubMedGoogle Scholar
  3. 3.
    Straumann A, et al. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124(33):1419–29.PubMedGoogle Scholar
  4. 4.
    Attwood SE, et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–16.CrossRefPubMedGoogle Scholar
  5. 5.
    Blanchard C, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(2):536–47.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Blanchard C, et al. A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 2011;127(1):208–17.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ngo P, et al. Eosinophils in the esophagus–peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101(7):1666–70.CrossRefPubMedGoogle Scholar
  8. 8.
    Molina-Infante J, et al. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008;14(9):1463–6.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Parfitt JR, et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19(1):90–6.CrossRefPubMedGoogle Scholar
  10. 10.
    van Rhijn BD, et al. Oesophageal baseline impedance values are decreased in patients with eosinophilic oesophagitis. United Eur Gastroenterol J. 2013;1(4):242–8.CrossRefGoogle Scholar
  11. 11.
    Liacouras CA, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.CrossRefPubMedGoogle Scholar
  12. 12.
    Al-Subu A, et al. The accuracy of endoscopic features in eosinophilic esophagitis: the experience in children from rural West Virginia. J Clin Gastroenterol. 2012;46(10):e83–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Gill RK, et al. Prevalence and characteristics of eosinophilic esophagitis in 2 ethnically distinct pediatric populations. J Allergy Clin Immunol. 2013;133:576–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Collins MH. Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin N Am. 2014;43(2):257–68.CrossRefGoogle Scholar
  15. 15.
    Saffari H, et al. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. JAllergy ClinImmunol. 2012;130(3):798–800.CrossRefGoogle Scholar
  16. 16.
    Papadopoulou A, et al. Management guidelines of eosinophilic esophagitis in childhood. J Pediatr Gastroenterol Nutr. 2014;58(1):107–18.CrossRefPubMedGoogle Scholar
  17. 17.
    Mulder DJ, et al. Clinical features distinguish eosinophilic and reflux-induced esophagitis. J Pediatr Gastroenterol Nutr. 2013;56(3):263–70.CrossRefPubMedGoogle Scholar
  18. 18.
    Abonia JP, Franciosi JP, Rothenberg ME. TGF-beta1: Mediator of a feedback loop in eosinophilic esophagitis–or should we really say mastocytic esophagitis? J Allergy Clin Immunol. 2010;126(6):1205–7.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Dellon ES, et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol. 2011;106(2):264–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Kirsch R, et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;44(1):20–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Aceves SS, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119(1):206–12.CrossRefPubMedGoogle Scholar
  22. 22.
    Aceves SS, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126(6):1198–204.e4.CrossRefPubMedGoogle Scholar
  23. 23.
    Niranjan R, et al. Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol. 2013;304(12):G1087–94.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol. 2012;303(11):G1175–87.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Steiner SJ, Kernek KM, Fitzgerald JF. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42(5):506–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Fox VL, et al. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003;57(1):30–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Remedios M, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63(1):3–12.CrossRefPubMedGoogle Scholar
  28. 28.
    Sant'Anna AM, et al. Eosinophilic esophagitis in children: symptoms, histology and pH probe results. J Pediatr Gastroenterol Nutr. 2004;39(4):373–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Steiner SJ, et al. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol. 2004;99(5):801–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102(6):1301–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Ruchelli E, et al. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol. 1999;2(1):15–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Shah A, et al. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol. 2009;104(3):716–21.CrossRefPubMedGoogle Scholar
  33. 33.
    Orel R, et al. Eosinophilic esophagitis that develops during therapy with proton pump inhibitors : case series and possible mechanisms. Acta Gastroenterol Belg. 2016;79(2):245–50.PubMedGoogle Scholar
  34. 34.
    Dellon ES, et al. Diagnosis of eosinophilic esophagitis after fundoplication for 'refractory reflux': implications for preoperative evaluation. Dis Esophagus. 2010;23(3):191–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Furuta GT, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133(4):1342–63.CrossRefPubMedGoogle Scholar
  36. 36.
    Cheng E, Souza RF, Spechler SJ. Eosinophilic esophagitis: interactions with gastroesophageal reflux disease. Gastroenterol Clin N Am. 2014;43(2):243–56.CrossRefGoogle Scholar
  37. 37.
    Cheng E, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–32.CrossRefPubMedGoogle Scholar
  38. 38.
    Zhang X, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One. 2012;7(11):e50037.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Hirano I. Editorial: should patients with suspected eosinophilic esophagitis undergo a therapeutic trial of proton pump inhibition? Am J Gastroenterol. 2013;108(3):373–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Molina-Infante J, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9(2):110–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Molina-Infante J, Katzka DA, Dellon ES. Proton pump inhibitor-responsive esophageal eosinophilia: a historical perspective on a novel and evolving entity. Rev Esp Enferm Dig. 2015;107(1):29–36.PubMedGoogle Scholar
  42. 42.
    Molina-Infante J, Katzka DA, Gisbert JP. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther. 2013;37(12):1157–64.CrossRefPubMedGoogle Scholar
  43. 43.
    Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;14:13–22.e1.CrossRefPubMedGoogle Scholar
  44. 44.
    Krarup AL, et al. Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol. 2010;45(3):273–81.CrossRefPubMedGoogle Scholar
  45. 45.
    Sherrill JD, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718–29.CrossRefPubMedGoogle Scholar
  46. 46.
    Souza RF, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137(5):1776–84.CrossRefPubMedGoogle Scholar
  47. 47.
    Molina-Infante J, van Rhijn BD. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol. 2015;29(5):749–58.CrossRefPubMedGoogle Scholar
  48. 48.
    Molina-Infante J, et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther. 2014;40(8):955–65.CrossRefPubMedGoogle Scholar
  49. 49.
    Molina-Infante J, et al. Long-term loss of response in proton pump inhibitor-responsive esophageal eosinophilia is uncommon and influenced by CYP2C19 genotype and rhinoconjunctivitis. Am J Gastroenterol. 2015;110:1567–75.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Pediatric Gastroenterology, Department of PediatricsCentro Hospitalar S. JoãoPortoPortugal

Personalised recommendations